The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.

Saved in:
Bibliographic Details
Title: The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.
Authors: Berg M; a Department of Medical Physics , Vejle Hospital , Vejle , Denmark., Lorenzen EL; b Laboratory of Radiation Physics , Odense University Hospital , Odense , Denmark., Jensen I; c Department of Medical Physics , Aalborg University Hospital , Aalborg , Denmark., Thomsen MS; d Department of Medical Physics , Aarhus University Hospital , Denmark Aarhus., Lutz CM; d Department of Medical Physics , Aarhus University Hospital , Denmark Aarhus., Refsgaard L; a Department of Medical Physics , Vejle Hospital , Vejle , Denmark., Nissen HD; a Department of Medical Physics , Vejle Hospital , Vejle , Denmark., Offersen BV; e Department of Oncology , Aarhus University Hospital , Denmark.
Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2018 Jan; Vol. 57 (1), pp. 113-119. Date of Electronic Publication: 2017 Dec 05.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1651-226X
DOI:10.1080/0284186X.2017.1406139